Vice President, Quality Assurance

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you’re ready to join us at the edge of something unstoppable, let’s make a profound impact together for our patients, for your career, for what’s beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Vice President, Quality Assurance The Vice President, Quality Assurance serves as the senior leader accountable for defining and driving Olema’s global quality strategy, systems, and governance across the full product lifecycle, including clinical development, manufacturing, pharmacovigilance, and commercial. This leader is the primary voice of Quality at the executive level and ensures a phase-appropriate, risk-based approach to quality that reflects the needs of oncology drug development, where patient safety, data integrity, and speed are critical. Operating with appropriate independence, this role partners cross-functionally and leads an established Quality leadership team across GCP, GMP, and GPV - aligning priorities, strengthening execution, and ensuring inspection readiness as Olema advances toward late-stage development. This role is based out of our either our San Francisco, CA or Boston, MA office and will require some travel as needed. As Vice President, Quality Assurance , your work will primarily encompass: Quality Strategy & Leadership Define and drive a pragmatic, phase-appropriate and unified Quality strategy aligned with Olema’s pipeline and corporate objectives Serve as the senior Quality leader, establishing clear governance, decision-making frameworks, and escalation pathways Lead and develop Quality leadership across GCP, GMP, and GPV, enabling strong execution and maintaining clear accountability Foster a culture of quality, integrity, and patient focus across the organization Act as escalation point for significant quality, compliance, and patient safety risks Ensure ongoing inspection readiness across clinical, manufacturing, and safety domains Quality Systems & Governance Set expectations and direction for a scalable, integrated, and sustainable Quality Management framework spanning clinical through commercial stages Ensure effectiveness and evolution of Quality systems through oversight of functional leaders across the QA function Drive consistency in quality processes, risk management approaches, and data integrity standards across the organization Establish clear quality metrics and reporting to enable risk visibility and informed decision-making Clinical Quality (GCP) Ensure Quality approaches appropriately support the execution of oncology clinical trials Provide oversight of clinical quality and CRO management to ensure patient safety and data integrity Partner with Clinical and Regulatory to support inspection-ready programs and submissions Manufacturing & Commercial Readiness (GMP) Ensure Quality strategy supports manufacturing scale-up and readiness for late-stage development and commercialization Oversee GMP Quality through established leadership, ensuring appropriate CMO/CDMO oversight and inspection preparedness Provide Quality input into CMC, validation, and supply chain readiness activities Pharmacovigilance Quality (GPV) Oversee the pharmacovigilance quality framework, ensuring compliance, data integrity, and effective safety surveillance Ensure PV systems and vendors are appropriately governed and inspecti